Suman Chatterjee, Ph.D.
Affiliations: | Biological Sciences | Duquesne University, Pittsburgh, PA, United States |
Area:
Cell biologyGoogle:
"Suman Chatterjee"Mean distance: 17.64 (cluster 28) | S | N | B | C | P |
Parents
Sign in to add mentorRichard Elinson | grad student | 2013 | Duquesne University | |
(Differential expression of nodal-signal transducers and global transcriptional repression commit vegetal cells in Eleutherodactylus coqui to form nutritional endoderm.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yochum ZA, Cades J, Wang H, et al. (2018) Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene |
Han J, Goldstein LA, Hou W, et al. (2018) HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC. Autophagy. 1-14 |
Yochum ZA, Chatterjee S, Huang EH, et al. (2018) Abstract 5889: TWIST1 is a key mediator of HGF-MET-driven resistance to targeted therapies in EGFR mutant and MET-driven lung cancer Cancer Research. 78: 5889-5889 |
Chatterjee S, Burns TF. (2017) Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. International Journal of Molecular Sciences. 18 |
Yochum ZA, Cades J, Mazzacurati L, et al. (2017) A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-driven Lung Cancer. Molecular Cancer Research : McR |
Chatterjee S, Huang EH, Christie I, et al. (2017) Reactivation of the p90RSK-CDC25C pathway leads to bypass of the ganetespib induced G2/M arrest and mediates acquired resistance to ganetespib in KRAS mutant NSCLC. Molecular Cancer Therapeutics |
Chatterjee S, Huang EH, Christie I, et al. (2017) Acquired resistance to the Hsp90 inhibitor, ganetespib in KRAS mutant NSCLC is mediated via reactivation of the ERK-p90RSK-mTOR signaling network. Molecular Cancer Therapeutics |
Chatterjee S, Huang EH, Christie I, et al. (2017) Abstract 4152: The p90RSK-CDC25C signaling pathway leads to bypass of the ganetespib induced G2/M arrest and mediates acquired resistance to ganetespib inKRASmutant NSCLC Cancer Research. 77: 4152-4152 |
Chatterjee S, Huang EH, Burns TF. (2016) Abstract 2942: p90 Ribosomal S6 kinase mediates acquired resistance to ganetespib in KRAS mutant NSCLC Cancer Research. 76: 2942-2942 |
Chatterjee S, Burns TF. (2015) Abstract 762: Ganetespib resistance inKRASmutant NSCLC is mediated through bypassing the G2/M checkpoint and reactivating the PI3K/MTOR pathway Cancer Research. 75: 762-762 |